In the adjuvant treatment, greater occurrence of neutropenia was observed, as, among the 39 participants, it was presented by 26 66.7%, representing 52% of the 50 neutropenic events.
En el tratamiento adyuvante se observó una mayor ocurrencia de neutropenia, ya que, entre las 39 participantes, 26 de ellas 66,7% lo presentaron, representando 52% de los 50 eventos neutropénicos.
No tratamento adjuvante observou-se maior ocorrência de neutropenia, pois, entre as 39 participantes, 26 delas 66,7% apresentaram, representando 52% dos 50 eventos neutropênicos.